Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Strides ‘Evaluating’ Mylan Claims Over Factory Lapses Cited By FDA

This article was originally published in PharmAsia News

Executive Summary

Drug firm Strides Shasun Ltd says it is "evaluating" claims from Mylan Inc involving US Food and Drug Administration complaints about three plants that the Indian company sold to the global generics drug giant as part of a high-profile $1.75bn deal two years ago.



Related Companies